Stericycle (SRCL) Reports In-Line Q2 EPS, Revenue Light

Go back to Stericycle (SRCL) Reports In-Line Q2 EPS, Revenue Light

Imperial Capital Downgrades Stericycle (SRCL) to Underperform

July 29, 2016 10:26 AM EDT

Imperial Capital downgraded Stericycle (NASDAQ: SRCL) from In-Line to Underperform with a price target of $93.50 (from $100.00).

Analyst Scott Levine commented, "We are lowering our rating on SRCL shares to Underperform from In-Line, and are lowering our one-year price target to $93.50 from $100. Our... More